iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Martin & Co. Inc. TN

Martin & Co. Inc. TN decreased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 4.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 19,325 shares of the financial services provider’s stock after selling 923 shares during the period. Martin & Co. Inc. TN’s holdings in iShares Biotechnology ETF were worth $2,555,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in IBB. Good Life Advisors LLC boosted its stake in shares of iShares Biotechnology ETF by 59.4% during the third quarter. Good Life Advisors LLC now owns 2,666 shares of the financial services provider’s stock worth $388,000 after buying an additional 993 shares during the period. Werba Rubin Papier Wealth Management raised its holdings in iShares Biotechnology ETF by 2.7% during the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after purchasing an additional 76 shares in the last quarter. Toth Financial Advisory Corp raised its holdings in iShares Biotechnology ETF by 19.1% during the third quarter. Toth Financial Advisory Corp now owns 41,862 shares of the financial services provider’s stock worth $6,095,000 after purchasing an additional 6,715 shares in the last quarter. Sequoia Financial Advisors LLC raised its holdings in iShares Biotechnology ETF by 8.3% during the third quarter. Sequoia Financial Advisors LLC now owns 2,608 shares of the financial services provider’s stock worth $380,000 after purchasing an additional 199 shares in the last quarter. Finally, Eastern Bank purchased a new position in iShares Biotechnology ETF in the third quarter valued at about $65,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock opened at $136.55 on Monday. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57. The business has a 50 day moving average price of $135.73 and a 200 day moving average price of $140.93.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.